| 0069-0284 | Ibrance | palbociclib | Pfizer Laboratories Div Pfizer Inc | NDA | Current |
| 0069-0284 | Ibrance | palbociclib | Pfizer Laboratories Div Pfizer Inc | NDA | Current |
| 0069-0284 | Ibrance | palbociclib | Pfizer Laboratories Div Pfizer Inc | NDA | Current |
| 0069-0284 | Ibrance | palbociclib | Pfizer Laboratories Div Pfizer Inc | NDA | Current |
| 0069-0486 | Ibrance | palbociclib | Pfizer Laboratories Div Pfizer Inc | NDA | Current |
| 0069-0486 | Ibrance | palbociclib | Pfizer Laboratories Div Pfizer Inc | NDA | Current |
| 0069-0486 | Ibrance | palbociclib | Pfizer Laboratories Div Pfizer Inc | NDA | Current |
| 0069-0486 | Ibrance | palbociclib | Pfizer Laboratories Div Pfizer Inc | NDA | Current |
| 0069-0688 | Ibrance | palbociclib | Pfizer Laboratories Div Pfizer Inc | NDA | Current |
| 0069-0688 | Ibrance | palbociclib | Pfizer Laboratories Div Pfizer Inc | NDA | Current |
| 0069-0688 | Ibrance | palbociclib | Pfizer Laboratories Div Pfizer Inc | NDA | Current |
| 0069-0688 | Ibrance | palbociclib | Pfizer Laboratories Div Pfizer Inc | NDA | Current |
| 63539-284 | Ibrance | palbociclib | US Pharmaceuticals | NDA | Current |
| 63539-284 | Ibrance | palbociclib | US Pharmaceuticals | NDA | Current |
| 63539-284 | Ibrance | palbociclib | U.S. Pharmaceuticals | NDA | Current |
| 63539-486 | Ibrance | palbociclib | US Pharmaceuticals | NDA | Current |
| 63539-486 | Ibrance | palbociclib | US Pharmaceuticals | NDA | Current |
| 63539-486 | Ibrance | palbociclib | U.S. Pharmaceuticals | NDA | Current |
| 63539-688 | Ibrance | palbociclib | US Pharmaceuticals | NDA | Current |
| 63539-688 | Ibrance | palbociclib | US Pharmaceuticals | NDA | Current |
| 63539-688 | Ibrance | palbociclib | U.S. Pharmaceuticals | NDA | Current |